To achieve a competitive advantage, key organisations are focused on R&D to build technologically enhanced applications. CELLINK, for example, released the most sophisticated 3D bioprinting technology, Bio X6, in November 2019, as well as Lumen X, which generates vascular structures. Fluicell, a Swedish business, has also introduced Biopixlar, a high-resolution bioprinting technique available in both 3D and 2D formats.
Companies are pursuing mergers, collaborations, and acquisitions in order to improve their production capabilities, application portfolio, and competitive difference. For example, in November 2019, BASF GmbH announced the purchase of Sculpteo, a provider of 3D printing services. This acquisition is intended to help BASF GmbH in the market and accelerate the development of new industrial 3D printing materials.
Increased R&D investments, increased frequency of chronic illnesses, a restricted number of organ donors, and technical improvements done by leading companies are major drivers driving market expansion. Furthermore, the increasing use of 3D printing in the healthcare, pharmaceutical, and biotechnology industries is likely to boost market growth. Furthermore, increased public and private funding for bioprinting research projects is likely to drive market growth. The Global 3D Bioprinting industry research provides a comprehensive analysis of the industry. The research provides a thorough examination of major segments, trends, drivers, constraints, the competitive landscape, and factors that are significant in the market.
Research Methodology:
After secondary research provided a fundamental understanding of the worldwide 3D Bioprinting Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering 3D Bioprinting Market, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered.
The segmentation coverage of the study is provided below.
3D Bioprinting Market based on Component:
3D Bioprinting Market based on Application:
- Research applications
- Clinical applications
3D Bioprinting Market based on End Users:
- Research Organizations and Academic Institutes,
- Biopharmaceutical companies
- Hospitals
3D Bioprinting Market based on Geography:
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
In 2022, the inkjet-based category accounted for the highest revenue share of 35.9%, since this technology allows for the printing of complex live organs or tissues on culture substrates using biomaterials such as bio-inks. The widespread use of inkjet-based printing in the medical industry is fueling the segment’s expansion. This paper discusses current research trends in inkjet printing as a bio-applicable technology, with a focus on tissue engineering and drug delivery systems. This category is expected to rise significantly during the projected period because to increased demand and greater reliability.
Magnetic levitation is expected to grow at the fastest CAGR of 13.7% throughout the projection period. The cost-effectiveness of the technology can be ascribed to the profitable expansion. With its upgraded features, increased speed, and precision, magnetic levitation technology is predicted to eliminate more than 80% of 3D bioprinting mistakes.
These bioprinters are also used to check for toxicity, print vascular muscle, and regenerate human cells. BioAssay, for example, has created a tissue-like structure using magnetic levitation-based devices. Magnetic levitation-based gadgets are expected to rise slowly throughout the projected period due to the quick adoption of newer technologies.
The widespread use of prescription tablets to treat a variety of chronic ailments is moving the industry for 3D bioprinting forward. Furthermore, the rising need for medications and the cost-effective use of bio-drugs employing this technology are propelling the industry.
The demand for medicinal tablets is rising as the number of pharmaceutical sector players grows. Millions of individuals worldwide utilise capsules and medical tablets on a regular basis. As a result, this category is predicted to increase rapidly throughout the projection period.
- This report illustrates the most vital attributes of the 3D Bioprinting Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the 3D Bioprinting Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the 3D Bioprinting Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the 3D Bioprinting Market.
List of Tables
TABLE 1. VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 2. VIRTUAL PRIVATE SERVER MARKET VALUE FOR 3D BIOPRINTERS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. VIRTUAL PRIVATE SERVER MARKET VALUE FOR BIOINKS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 5. VIRTUAL PRIVATE SERVER MARKET VALUE FOR RESEARCH APPLICATIONS, 2021-2030 (USD BILLION)
TABLE 6. VIRTUAL PRIVATE SERVER MARKET VALUE FOR CLINICAL APPLICATIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 8. VIRTUAL PRIVATE SERVER MARKET VALUE FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. VIRTUAL PRIVATE SERVER MARKET VALUE FOR BIOPHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. VIRTUAL PRIVATE SERVER MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. NORTH AMERICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 14. NORTH AMERICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 15. U.S VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 16. U.S VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 17. U.S VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 18. CANADA VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 19. CANADA VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 20. CANADA VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 21. MEXICO VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 22. MEXICO VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 23. MEXICO VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 24. EUROPE VIRTUAL PRIVATE SERVER MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 25. EUROPE VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 26. EUROPE VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 27. EUROPE VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 28. GERMANY VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 29. GERMANY VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 30. GERMANY VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 31. U.K VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 32. U.K VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 33. U.K VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 34. FRANCE VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 35. FRANCE VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. FRANCE VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 37. ITALY VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 38. ITALY VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. ITALY VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 40. SPAIN VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 41. SPAIN VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. SPAIN VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 43. ROE VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 44. ROE VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. ROE VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 46. ASIA PACIFIC VIRTUAL PRIVATE SERVER MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 47. ASIA PACIFIC VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 48. ASIA PACIFIC VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 49. ASIA PACIFIC VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 50. CHINA VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 51. CHINA VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 52. CHINA VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 53. INDIA VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 54. INDIA VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 55. INDIA VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 56. JAPAN VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 57. JAPAN VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. JAPAN VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 59. REST OF APAC VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 60. REST OF APAC VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. REST OF APAC VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 62. LATIN AMERICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 63. LATIN AMERICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. LATIN AMERICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 65. BRAZIL VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 66. BRAZIL VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 67. BRAZIL VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 68. ARGENTINA VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 69. ARGENTINA VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. ARGENTINA VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 71. MIDDLE EAST AND AFRICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 72. MIDDLE EAST AND AFRICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 73. MIDDLE EAST AND AFRICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 74. SAUDI ARABIA VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 75. SAUDI ARABIA VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 76. SAUDI ARABIA VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 77. UAE VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 78. UAE VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 79. UAE VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 80. REST OF MIDDLE EAST AND AFRICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 81. REST OF MIDDLE EAST AND AFRICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 82. REST OF MIDDLE EAST AND AFRICA VIRTUAL PRIVATE SERVER MARKET VALUE, BY END USERS, 2021-2030 (USD BILLION)
TABLE 83. ENVISIONTEC, INC. : FINANCIALS
TABLE 84. ENVISIONTEC, INC. : PRODUCTS & SERVICES
TABLE 85. ENVISIONTEC, INC. : RECENT DEVELOPMENTS
TABLE 86. ORGANOVO HOLDINGS, INC.: FINANCIALS
TABLE 87. ORGANOVO HOLDINGS, INC.: PRODUCTS & SERVICES
TABLE 88. ORGANOVO HOLDINGS, INC.: RECENT DEVELOPMENTS
TABLE 89. INVENTIA LIFE SCIENCE PTY LTD: FINANCIALS
TABLE 90. INVENTIA LIFE SCIENCE PTY LTD: PRODUCTS & SERVICES
TABLE 91. INVENTIA LIFE SCIENCE PTY LTD: RECENT DEVELOPMENTS
TABLE 92. POIETIS: FINANCIALS
TABLE 93. POIETIS: PRODUCTS & SERVICES
TABLE 94. POIETIS: RECENT DEVELOPMENTS
TABLE 95. VIVAX BIO, LLC: FINANCIALS
TABLE 96. VIVAX BIO, LLC: PRODUCTS & SERVICES
TABLE 97. VIVAX BIO, LLC: RECENT DEVELOPMENTS
TABLE 98. ALLEVI: FINANCIALS
TABLE 99. ALLEVI: PRODUCTS & SERVICES
TABLE 100. ALLEVI: RECENT DEVELOPMENTS
TABLE 101. CYFUSE BIOMEDICAL K.K.: FINANCIALS
TABLE 102. CYFUSE BIOMEDICAL K.K.: PRODUCTS & SERVICES
TABLE 103. CYFUSE BIOMEDICAL K.K.: DEVELOPMENTS
TABLE 104. 3D BIOPRINTING SOLUTIONS: FINANCIALS
TABLE 105. 3D BIOPRINTING SOLUTIONS: PRODUCTS & SERVICES
TABLE 106. 3D BIOPRINTING SOLUTIONS: RECENT DEVELOPMENTS
TABLE 107. CELLINK GLOBAL: FINANCIALS
TABLE 108. CELLINK GLOBAL: PRODUCTS & SERVICES
TABLE 109. CELLINK GLOBAL: RECENT DEVELOPMENTS
TABLE 110. REGEMAT 3D S.L.: FINANCIALS
TABLE 111. REGEMAT 3D S.L.: PRODUCTS & SERVICES
TABLE 112. REGEMAT 3D S.L.: RECENT DEVELOPMENTS
